Ipamorelin (10mg)
US$ 24.39
aod9604 clinical trials efficacy side effects fat loss AOD-9604 Peptide aod9604 human clinical trials weight
Description
1 , e16228
Shaking the vial instead of gentle swirling damages peptide structure
Lipolysis via the 3-adrenergic receptor (the assumed mechanism) The most accepted hypothesis is that AOD-9604 indirectly activates 3-adrenergic receptors in adipocytes
Animal studies confirmed AOD9604s fat-reducing potential
BPC-157 stands for Body Protection Compound-157, derived from a human gastric juice protein
